Effectiveness and Safety of Risankizumab Induction Therapy in Crohn's Disease: Prospective Real-World Experience in a Large Tertiary Center

被引：0
|
作者：
Zinger, Adar [1 ]
Choi, David K. [1 ]
Choi, Natalie K. [1 ]
Garcia, Nicole M. [1 ]
Cohen, Russell D. [1 ]
Dalal, Sushila [2 ]
Cleveland, Noa Krugliak [1 ]
Rubin, David T. [1 ]
机构：
[1] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Chicago, IL USA
[2] Univ Chicago Med, Chicago, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1094
引用
收藏
页码：S834 / S834
页数：1
相关论文
共 50 条
  • [41] Real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn's disease
    Garg, Rajat
    Aggarwal, Manik
    Mohammed, Abdul
    Achkar, Jean Paul
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin
    Qazi, Taha
    Rieder, Florian
    Regueiro, Miguel
    Click, Benjamin
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2023, 42 (05) : 718 - 723
  • [42] AIRIS-Crohn: Results on the Effectiveness and Safety of Risankizumab in the Medium Term in Real-World Clinical Practice
    Mateos, A. M. Caballero
    Martin, R. V. Olmedo
    Gijon-Villanova, R.
    Gutierrez-Holanda, C.
    Fernandez-Moreno, N.
    Martin-Rodriguez, M. D. M.
    Silva-Albarellos, E.
    Rodriguez-Gonzalez, F. J.
    Hernandez-Martinez, A.
    Benitez, J. M.
    Mata, F. J.
    Trapero-Martinez, A. M.
    Valdes-Delgado, T.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1568 - i1570
  • [43] REAL-WORLD EFFECTIVENESS AND SAFETY OF USTEKINUMAB AND VEDOLIZUMAB IN ELDERLY PATIENTS WITH CROHN'S DISEASE
    Garg, Rajat
    Aggarwal, Manik
    Mohammed, Abdul
    Achkar, Jean-Paul
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin L.
    Rieder, Florian
    Qazi, Taha
    Regueiro, Miguel D.
    Click, Benjamin H.
    GASTROENTEROLOGY, 2021, 160 (06) : S560 - S560
  • [44] A Multi-Center Study of the Outcomes of Risankizumab Use Stratified by Prior Ustekinumab Exposure in Patients With Crohn's Disease: A Real-World Experience
    Manski, Scott
    Andreone, Michael
    Swaminathan, Shreya
    Cordero-Baez, Fernando
    Sanchez, Jonathan Colon
    Kantor, Jenna
    Keith, Scott
    Shmidt, Eugenia
    Shivashankar, Raina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S820 - S821
  • [45] Upadacitinib Is Safe and Effective for Crohn's Disease: Real-World Data from a Tertiary Center
    Traboulsi, Cindy
    Ayoub, Fares
    Silfen, Alexa
    Rodriguez, Tina G.
    Rubin, David T.
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (02) : 385 - 388
  • [46] Upadacitinib Is Safe and Effective for Crohn’s Disease: Real-World Data from a Tertiary Center
    Cindy Traboulsi
    Fares Ayoub
    Alexa Silfen
    Tina G. Rodriguez
    David T. Rubin
    Digestive Diseases and Sciences, 2023, 68 : 385 - 388
  • [47] Effectiveness and Safety of Induction Therapy with Upadacitinib for the Treatment of Perianal Crohn's Disease : Real-World Data from a GETAID Multicentre Cohort Study
    Richard, N.
    Altwegg, R.
    Seksik, P.
    Nancey, S.
    Nachury, M.
    Laharie, D.
    Amiot, A.
    Vuitton, L.
    Peyrin-Biroulet, L.
    Allez, M.
    Rouillon, C.
    Coffin, B.
    Pelletier, A. L.
    Uzzan, M.
    Amil, M.
    Hupe, M.
    Fumery, M.
    Bozon, A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1225 - I1227
  • [48] Early real-world effectiveness of ustekinumab for Crohn's disease
    Harris, Richard James
    McDonnell, Martin
    Young, David
    Bettey, Marion
    Downey, Louise
    Pigott, Lucinda
    Felwick, Richard
    Gwiggner, Markus
    Cummings, J. R. Fraser
    FRONTLINE GASTROENTEROLOGY, 2020, 11 (02) : 111 - 116
  • [49] THE REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN THE TREATMENT OF CROHN'S DISEASE
    Johnson, Amanda M.
    Barsky, Maria
    Ahmed, Waseem
    Zullow, Samantha
    Galati, Jonathan S.
    Jairath, Vipul
    Narula, Neeraj
    Peerani, Farhad
    Click, Benjamin H.
    Coburn, Elliot
    Dang, Thucnhi T.
    Gold, Stephanie
    Agrawal, Manasi
    Garg, Rajat
    Aggarwal, Manik
    Mohammad, Danah
    Halloran, Brendan P.
    Kochhar, Gursimran
    Todorowski, Hannah
    Mohy-Ud-Din, Nabeeha
    Izanec, James L.
    Teeple, Amanda M.
    Gasink, Christopher
    Muser, Erik
    Ding, Zhijie
    Swaminath, Arun
    Lakhani, Komal
    Hogan, Daniel
    Datta, Samit
    Ungaro, Ryan C.
    Singh, Siddharth
    Boland, Brigid
    Bohm, Matthew
    Fischer, Monika
    Sashi, Sagi
    Afzali, Anita
    Ullman, Thomas
    Lawlor, Garrett
    Baumgart, Daniel C.
    Chang, Shannon
    Hudesman, David
    Lukin, Dana J.
    Scherl, Ellen J.
    Colombel, Jean Frederic
    Sands, Bruce E.
    Siegel, Corey A.
    Regueiro, Miguel D.
    Sandborn, William J.
    Bruining, David H.
    Kane, Sunanda V.
    GASTROENTEROLOGY, 2021, 160 (06) : S121 - S121
  • [50] Comparative Effectiveness of Vedolizumab vs. Infliximab Induction Therapy in Ulcerative Colitis: Experience of a Real-World Cohort at a Tertiary Inflammatory Bowel Disease Center
    Allamneni, Chaitanya
    Venkata, Krishna
    Yun, Huifeng
    Xie, Fenglong
    DeLoach, Lindsey
    Malik, Talha A.
    GASTROENTEROLOGY RESEARCH, 2018, 11 (01) : 41 - 45
12345